TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BioNema AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
292
|
229
|
340 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
28
|
29
|
106 |
| EBITDA |
34
|
38
|
115 |
| Total assets |
220
|
204
|
256 |
| Current assets |
181
|
162
|
202 |
| Current liabilities |
28
|
17
|
49 |
| Equity capital |
192
|
187
|
196 |
| - share capital |
9
|
9
|
10 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
87.3%
|
91.7%
|
76.6% |
| Turnover per employee |
146
|
114
|
170 |
| Profit as a percentage of turnover |
9.6%
|
12.7%
|
31.2% |
| Return on assets (ROA) |
12.7%
|
14.2%
|
41.4% |
| Current ratio |
646.4%
|
952.9%
|
412.2% |
| Return on equity (ROE) |
14.6%
|
15.5%
|
54.1% |
| Change turnover |
62
|
-84
|
-25 |
| Change turnover % |
27%
|
-27%
|
-7% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.